Is Orthovita Working Hard Enough for You?
Thu, 02/12/2010 - 23:41 by Seth Jayson
Margins matter. The more Orthovita (Nasdaq: VITA) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy margins often separate pretenders from the best stocks in the market. That's why I check on my holdings' margins at least once a quarter. I'm looking for the absolute numbers, comparisons to sector peers and competitors, and any trend that may tell me how strong Orthovita's competitive position could be.
Here's the current margin snapshot for Orthovita and some of its sector and industry peers and direct competitors.
TTM Gross Margin
TTM Operating Margin
TTM Net Margin
| CR Bard (NYSE: BCR)|
| Baxter International (NYSE:BAX)|
| NuVasive (Nasdaq: NUVA)|
Source: Capital IQ, a division of Standard & Poor's. TTM = trailing 12 months.
Unfortunately, that table doesn't tell us much about where Orthovita has been, or where it's going. A company with rising gross and operating margins often fuels its growth by increasing demand for its products. If it sells more units while keeping costs in check, its profitability increases. Conversely, a company with gross margins that inch downward over time is often losing out to competition, and possibly engaging in a race to the bottom on prices. If it can't make up for this problem by cutting costs -- and most companies can't -- then both the business and its shares face a decidedly bleak outlook.
Of course, over the short term, the kind of economic shocks we recently experienced can drastically affect a company's profitability. That's why I like to look at five fiscal years' worth of margins, along with the results for the trailing 12 months (TTM), the last fiscal year, and last fiscal quarter (LFQ). You can't always reach a hard conclusion about your company's health, but you can better understand what to expect, and what to watch.
Here's the margin picture for Orthovita over the past few years.
(Because of seasonality in some businesses, the numbers for the last period on the right -- the TTM figures -- aren't always comparable to the FY results preceding them.)
Here's how the stats break down:
- Over the past five years, gross margin peaked at 67.8% and averaged 64.8%. Operating margin peaked at (0.7%) and averaged (21.9%). Net margin peaked at (4.2%) and averaged (29.1%).
- TTM gross margin is 66.7%, 190 basis points better than the five-year average. TTM operating margin is 1.5%, 2,340 basis points better than the five-year average. TTM net margin is (2.4%), 2,670 basis points better than the five-year average.
With net margins still negative, Orthovita clearly has some work left to do. But its strong improvement over the past several years is clearly a positive sign.
© 2010 UCLICK L.L.C.